ES245448A1 - Improvements in or relating to novel amidines and the preparation thereof - Google Patents

Improvements in or relating to novel amidines and the preparation thereof

Info

Publication number
ES245448A1
ES245448A1 ES0245448A ES245448A ES245448A1 ES 245448 A1 ES245448 A1 ES 245448A1 ES 0245448 A ES0245448 A ES 0245448A ES 245448 A ES245448 A ES 245448A ES 245448 A1 ES245448 A1 ES 245448A1
Authority
ES
Spain
Prior art keywords
group
reaction
ammonia
general formula
integer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0245448A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES245448A1 publication Critical patent/ES245448A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention comprises compounds of the general formula: p <FORM:0868552/IV (b)/1> and acid addition salts thereof, wherein R1 and R2 are the same or different and each is a hydrogen atom or an aliphatic hydrocarbon radical containing from 1 to 4 carbon atoms, or the group R1R2N- is a piperidino, pyrrolidino, morpholino, piperazino, or N-benzhydrylpiperazino group n is an integer from 7 to 12 and A is an arylene group and is a 1 : 4-phenylene group which may be substituted in the positions ortho with respect to the alkyleneoxyl chain with a methyl or methoxyl group or a halogen atom, or is a 2 : 6-naphthylene group, and the preparation thereof by converting the cyano group in a compound of the general formula: <FORM:0868552/IV (b)/2> into an amidino group by methods known per se for such group conversions. Preferred methods (a) by reaction with an alcohol to form the imino ether followed by reaction of the latter with ammonia or an ammonium salt (b) by reaction with ammonium this cyanate or an ammonium arenesulphonate in the presence of ammonia (c) by reaction with an alkali metal amide in the presence of ammonia and (d) by reaction with ammonia or urea in the presence of an inorganic condensing agent. The o -amino-substituted-aminoalkoxynitriles used as starting materials are prepared by reacting a sodium salt of a hydroxy nitrile, HO-A-CN with an excessive proportion of an a -o -alkylene dibromide, separating the o -bromoalkoxynitrile from the a :o -bis-p-cyanoaryleneoxyalkane also formed and reacting the former with an amine R1R2NH. The first Provision Specification discloses compounds of the general formula: <FORM:0868552/IV (b)/3> wherein additionally n is an integer from 6 to 14 inclusive and R1 and R2 are hydrogen or C1-6 aliphatic hydrocarbon radicals.ALSO:Pharmaceutical preparations comprise a compound of the general formula <FORM:0868552/VI/1> or an acid addition salt thereof, wherein R1 and R2 are the same or different and each is a hydrogen atom or an aliphatic C1-4 hydrocarbon radical or the group R1R2N is a piperidino, pyrrolidino, morpholino, piperazino or N1-benzhydrylpiperazino group n is an integer from 7 to 12 and A is an aryline group and is a 1 : 4-phenylene group which may be substituted in the positions ortho with respect to the alkyleneoxyl chain with a methyl or methoxyl group or a halogen atom, or is a 2 : 6-naphthylene group, together with an acceptable carrier. The preparations are made by the admixture of the aforesaid active ingredient with the carrier therefor. Suitable preparations include tablets, capsules, suppositories, a suspension in syrup or oil or an aqueous suspension containing, if desired, a suitable suspending agent. An example discloses the preparation of a tablet containing p-10-diethylaminodecyloxybenzamidine sulphate.
ES0245448A 1957-12-03 1958-11-19 Improvements in or relating to novel amidines and the preparation thereof Expired ES245448A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB37608/57A GB868552A (en) 1957-12-03 1957-12-03 Improvements in or relating to novel amidines and the preparation thereof

Publications (1)

Publication Number Publication Date
ES245448A1 true ES245448A1 (en) 1959-06-01

Family

ID=10397709

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0245448A Expired ES245448A1 (en) 1957-12-03 1958-11-19 Improvements in or relating to novel amidines and the preparation thereof

Country Status (2)

Country Link
ES (1) ES245448A1 (en)
GB (1) GB868552A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1267009A (en) * 1969-07-25 1972-03-15
DE4309285A1 (en) * 1993-03-23 1994-09-29 Boehringer Ingelheim Kg Heterocyclic-containing amidine derivatives, their preparation and use
JP4320260B2 (en) 2002-03-06 2009-08-26 富山化学工業株式会社 Novel arylamidine derivatives or salts thereof
WO2006011499A1 (en) * 2004-07-28 2006-02-02 Toyama Chemical Co., Ltd. Novel arylamidine derivative, salt thereof, and antifungal containing these

Also Published As

Publication number Publication date
GB868552A (en) 1961-05-17

Similar Documents

Publication Publication Date Title
GB1325192A (en) Phloroglucinol derivatives
US3122546A (en) 4, 7-diamino-2-(substituted)-n-substituted-6-pteridinecarboxamides
ES245448A1 (en) Improvements in or relating to novel amidines and the preparation thereof
GB989013A (en) New guanidines and process for their manufacture
GB972888A (en) New 2-amino-(mono- or di-substituted)-ethyl-guanidines
GB1489711A (en) 1-phenoxyphenyl-piperazine derivatives process for their preparation and pharmaceutical compositions containing the
GB1016240A (en) Guanidine derivatives and a process for the manufacture thereof
GB1026401A (en) Isatin thiosemicarbazones,their preparation and pharmaceutical formulations containing them
GB1449802A (en) Piperazine derivatives and compositions containing them for treating parkinsons disease
GB875562A (en) Improvements in and relating to pyrimidine derivatives and the preparation thereof
GB983118A (en) Improvements in and relating to substituted pteridine compounds
GB1037655A (en) Di(aralkyl)amines
GB1076867A (en) Improvements in or relating to 2,4-diamino-6-substituted pyrimidines
GB1022955A (en) Process for the manufacture of n-substituted guanidine compounds
GB1280887A (en) New isothiocyano-diphenylamines their production and compositions containing same
US3174973A (en) Piperidyl norbornanes
US3452092A (en) N-substituted o-benzoylbenzamide
GB982945A (en) Phenylalanine derivatives
GB873781A (en) Novel sulphanilamido-pyrimidines and acid addition salts thereof and a process for the manufacture of same
GB1012619A (en) Improvements in or relating to dibenzocyclohepta-diene and -triene derivatives
GB1005728A (en) New amino-guanidines and process for their manufacture
GB1071815A (en) Phenothiazine derivatives
GB953464A (en) Cyclic amides
ES270688A1 (en) Morpholinones
GB985354A (en) í¸-piperideinoalkyl guanidine derivatives